Pfizer's stock surges as the pharmaceutical company reports stronger-than-expected earnings, raised profit forecasts, and ...

Company rebuilding following decline in demand for its covid products, slashing about €6.2bn from its spending and focusing ...

Pfizer's stock soared following robust sales of COVID-19 products and key drugs, leading to stronger-than-expected earnings and an increased profit forecast for 2025.

Pfizer raised its full-year profit forecast on Tuesday while reporting second-quarter results that topped Wall Street ...

Pfizer reported a jump in second quarter profits Tuesday behind higher sales of Covid 19 products and some other ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Many viruses circulate seasonally, picking up as the weather cools in the fall and winter. So it’s true that fewer people get ...

Palantir Technologies soars with AI pivot, Pfizer holds steady, Caterpillar warns in contrasting earnings reports, offering investors a mix of optimism and caution in the tech, pharmaceutical, and ...

The Health and Human Services secretary said he is reviewing whether to remove the medical experts on the U.S. Preventive Services Task Force who advise on cancer screenings, HIV prevention drugs, and ...